Under construction – not a live service
Sign in
Taking people in FranceNo phase

Adapts a fatigue management program for adults with sickle cell disease

Tests an adapted fatigue program in adults with sickle cell disease and tiredness.

Plain-language title generated from the registry record
Registry title: Adapting the FACETS Program to Sickle Cell Disease

Key facts

Where
Grenoble and Le Chesnay, FranceSee the 2 sites

Where in France

  • CHU Grenoble AlpesGrenoble, FranceTaking people
  • Hospital VersaillesLe Chesnay, FranceNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Versailles Hospital
Trial code
NCT06650813
Record updated
19 August 2025
Original description
Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).Read full original descriptionShow less

Adapting the FACETS Fatigue Management Program to Sickle Cell Disease

Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).

Inclusion: Participant having freely given his oral agreement; Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta); Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises.

Exclusion: Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study, in particular the primary and secondary endpoints; Participants with another chronic pathology causing fatigue; Participants in vaso-occlusive crisis (VOC) or hospitalization; Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).

ClinicalTrials.gov NCT06650813